Skip to main content
OpenTrials
Completed

NCT Number: NCT03225872

Biology of Osteosarcoma (BOOST) Registry and Biobank

Osteosarcoma is very rare cancer of the bone. The investigator started the BOOST registry and biobank to make sure every patient has the opportunity to participate in research.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteosarcoma Bone Diseases Bone Neoplasms Musculoskeletal Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Bone Tissue Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Sarcoma

Age range

0 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Masonic Cancer Center

Minneapolis, Minnesota, 55455, United States

About this study

Summary to include:

  • Samples of saliva, blood and/or other stored material such as slides or leftover diagnostic material. If available the investigator may ask you for deciduous (baby) teeth.
  • Questionnaire information, including health history, growth and development, physical activity and family medical history information.
  • If you have been diagnosed with a osteosarcoma or another condition the investigator is interested inthe investigator will ask you release medical record information relating to diagnosis and treatment of osteosarcoma, other cancers, blood disorders, and similar conditions. If this step applies to you then you will be asked to sign a separate form.
  • You may be asked to contact your biological parents and full biological siblings to ask them about participating in the study.
  • If you agree you may be contacted in the future. You will be able to decline any future information or studies at any point.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Proband Inclusion criteria: A diagnosis or suspected diagnosis of osteosarcoma (ICCC 9180-9200)

Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with osteosarcoma (ICCC 9180-9200)

Exclusion criteria

  • Does not understand English.

Treatment and study plan

Primary outcomes

  1. Determine if genes can determine osteosarcoma

    Time frame: Baseline

    To do this the investigator will compare the genes of people with osteosarcoma to the genes of people who do not have these conditions.

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Acronym: BOOST

Important dates

Study start
2017
Primary completion
2020
Study completion
2020
First posted
Jul 21, 2017
Registry last updated
Dec 2, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.